Pathological response and clinical outcomes in operable triple-negative breast cancer with cisplatin added to standard neoadjuvant chemotherapy.

Autor: J. T., Georgy, A., Singh, A. O., John, A., Joel, A. G., Andrews, D. B., Thumaty, G., Rebekah, E., Sigamani, J., Chandramohan, M. T., Manipadam, A. J., Cherian, D. T., Abraham, M. J., Paul, R., Balakrishnan, S., Backianathan, R. T., Chacko
Zdroj: Journal of the Czech & Slovak Societies for Oncology / Klinická Onkologie; 2021, Vol. 34 Issue 1, p49-55, 7p
Databáze: Complementary Index